Countermotion to shareholder meeting on April 27...Bayer is carrying out an ever increasing number of dangerous drug trials in poor countries, because they offer a large reservoir of test subjects, low prices, fast procedures and little supervision by the authorities. In India alone, there have been at least 138 fatalities as a result of BAYER's drug trials on humans in the last four years. The Board of Management bears responsibility for this. [The Resource Centre invited Bayer to respond - see Bayer's response below]